TrialEpilepsia open2024

Long-term efficacy and safety of adjunctive perampanel in patients from the Asia-Pacific region with refractory focal-onset seizures in Study 335 open-label extension.

Takuji Nishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.